HIV molecular immunology database

 

Search CTL/CD8+ T-Cell Epitope Database

Found 5 matching records:

Displaying record number 14

Download this epitope record as JSON.

HXB2 Location Gag(18-42)
p17(18-42)
DNA(841..915)
Gag Epitope Map
Author Location p17(18-42 PV22)
Epitope KIRLRPGGKKKYKLKHIVWASRELE Epitope Alignment
Species (MHC/HLA) human(A3)
Immunogen HIV-1 infection
Experimental methods  
Keywords  

Notes

References

Jassoy1993 C. Jassoy, T. Harrer, T. Rosenthal, B. A. Navia, J. Worth, R. P. Johnson, and B. D. Walker. Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Lymphocytes Release gamma Interferon, Tumor Necrosis Factor alpha (TNF-alpha), and TNF-beta when They Encounter Their Target Antigens. J. Virol., 67:2844-2852, 1993. In this study the ability of HIV-1-specific CTL clones derived from seropositive persons to release gamma interferon (IFN-$\gamma$), tumor necrosis factor alpha (TNF-$\alpha$), and TNF-$\beta$ upon contact with target cells presenting viral antigen was assessed. Epitopes: p17: KIRLRPGGKKKYKLKHIVWASRELE, A3; gp41: VERYLKDQQL, B14 and A28, ERYLKDQQL, B14; RT: AIFQSSMTKILEPFRKQNPDIVIYQ, A11; and Nef SQRRQDILDLWIYHTQGYFPDWQNY, B13. PubMed ID: 7682629. Show all entries for this paper.


Displaying record number 453

Download this epitope record as JSON.

HXB2 Location Pol(313-337)
RT(158-182)
DNA(3021..3095)
Pol Epitope Map
Author Location RT(325-349 PV22)
Epitope AIFQSSMTKILEPFRKQNPDIVIYQ Epitope Alignment
Species (MHC/HLA) human(A11)
Immunogen HIV-1 infection
Experimental methods  
Keywords  

Notes

References

Jassoy1993 C. Jassoy, T. Harrer, T. Rosenthal, B. A. Navia, J. Worth, R. P. Johnson, and B. D. Walker. Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Lymphocytes Release gamma Interferon, Tumor Necrosis Factor alpha (TNF-alpha), and TNF-beta when They Encounter Their Target Antigens. J. Virol., 67:2844-2852, 1993. In this study the ability of HIV-1-specific CTL clones derived from seropositive persons to release gamma interferon (IFN-$\gamma$), tumor necrosis factor alpha (TNF-$\alpha$), and TNF-$\beta$ upon contact with target cells presenting viral antigen was assessed. Epitopes: p17: KIRLRPGGKKKYKLKHIVWASRELE, A3; gp41: VERYLKDQQL, B14 and A28, ERYLKDQQL, B14; RT: AIFQSSMTKILEPFRKQNPDIVIYQ, A11; and Nef SQRRQDILDLWIYHTQGYFPDWQNY, B13. PubMed ID: 7682629. Show all entries for this paper.


Displaying record number 814

Download this epitope record as JSON.

HXB2 Location gp160(583-592)
gp41(72-81)
DNA(7971..8000)
gp160 Epitope Map
Author Location gp41(583-592 PV22)
Epitope VERYLKDQQL Epitope Alignment
VERYLKDQQL epitope logo
Species (MHC/HLA) human(B14)
Immunogen HIV-1 infection
Experimental methods  
Keywords  

Notes

References

Jassoy1993 C. Jassoy, T. Harrer, T. Rosenthal, B. A. Navia, J. Worth, R. P. Johnson, and B. D. Walker. Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Lymphocytes Release gamma Interferon, Tumor Necrosis Factor alpha (TNF-alpha), and TNF-beta when They Encounter Their Target Antigens. J. Virol., 67:2844-2852, 1993. In this study the ability of HIV-1-specific CTL clones derived from seropositive persons to release gamma interferon (IFN-$\gamma$), tumor necrosis factor alpha (TNF-$\alpha$), and TNF-$\beta$ upon contact with target cells presenting viral antigen was assessed. Epitopes: p17: KIRLRPGGKKKYKLKHIVWASRELE, A3; gp41: VERYLKDQQL, B14 and A28, ERYLKDQQL, B14; RT: AIFQSSMTKILEPFRKQNPDIVIYQ, A11; and Nef SQRRQDILDLWIYHTQGYFPDWQNY, B13. PubMed ID: 7682629. Show all entries for this paper.


Displaying record number 826

Download this epitope record as JSON.

HXB2 Location gp160(584-592)
gp41(73-81)
DNA(7974..8000)
gp160 Epitope Map
Author Location gp41(584-592 PV22)
Epitope ERYLKDQQL Epitope Alignment
ERYLKDQQL epitope logo
Species (MHC/HLA) human(B14)
Immunogen HIV-1 infection
Experimental methods  
Keywords  

Notes

References

Jassoy1993 C. Jassoy, T. Harrer, T. Rosenthal, B. A. Navia, J. Worth, R. P. Johnson, and B. D. Walker. Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Lymphocytes Release gamma Interferon, Tumor Necrosis Factor alpha (TNF-alpha), and TNF-beta when They Encounter Their Target Antigens. J. Virol., 67:2844-2852, 1993. In this study the ability of HIV-1-specific CTL clones derived from seropositive persons to release gamma interferon (IFN-$\gamma$), tumor necrosis factor alpha (TNF-$\alpha$), and TNF-$\beta$ upon contact with target cells presenting viral antigen was assessed. Epitopes: p17: KIRLRPGGKKKYKLKHIVWASRELE, A3; gp41: VERYLKDQQL, B14 and A28, ERYLKDQQL, B14; RT: AIFQSSMTKILEPFRKQNPDIVIYQ, A11; and Nef SQRRQDILDLWIYHTQGYFPDWQNY, B13. PubMed ID: 7682629. Show all entries for this paper.


Displaying record number 1025

Download this epitope record as JSON.

HXB2 Location Nef(103-127)
DNA(9103..9177)
Nef Epitope Map
Author Location Nef(103-127 PV22)
Epitope SQRRQDILDLWIYHTQGYFPDWQNY Epitope Alignment
Species (MHC/HLA) human(B13)
Immunogen HIV-1 infection
Experimental methods  
Keywords  

Notes

References

Jassoy1993 C. Jassoy, T. Harrer, T. Rosenthal, B. A. Navia, J. Worth, R. P. Johnson, and B. D. Walker. Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Lymphocytes Release gamma Interferon, Tumor Necrosis Factor alpha (TNF-alpha), and TNF-beta when They Encounter Their Target Antigens. J. Virol., 67:2844-2852, 1993. In this study the ability of HIV-1-specific CTL clones derived from seropositive persons to release gamma interferon (IFN-$\gamma$), tumor necrosis factor alpha (TNF-$\alpha$), and TNF-$\beta$ upon contact with target cells presenting viral antigen was assessed. Epitopes: p17: KIRLRPGGKKKYKLKHIVWASRELE, A3; gp41: VERYLKDQQL, B14 and A28, ERYLKDQQL, B14; RT: AIFQSSMTKILEPFRKQNPDIVIYQ, A11; and Nef SQRRQDILDLWIYHTQGYFPDWQNY, B13. PubMed ID: 7682629. Show all entries for this paper.


Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health